TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RVMD

Revolution Medicines Inc

Healthcare · Biotechnology

205.00$ +2.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement RVMD
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% – –
– 253.3% 183.4% 307.7% 636.1% 715.3% 3,551.3% – –
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% – –
– 253.3% 183.4% 307.7% 636.1% 715.3% 3,654.1% – –
– 46.7% 24.8% 49.9% 103.6% 114.7% 653.0% – –
– 300.0% 208.2% 357.5% 739.7% 830.0% 4,307.1% – –
– -200.0% -108.2% -257.5% -639.7% -730.0% -4,207.1% – –
– 0.6% 0.2% 0.2% 0.0% 27.3% 2.6% – –
– -207.2% -104.0% -252.5% -636.6% -704.1% -3,798.7% – –
– -6.7% -8.7% -0.9% -24.9% -1.2% -30.4% – –
– -207.2% -95.2% -251.6% -636.6% -703.0% -3,768.3% – –
– -197.9% -97.1% -237.1% -611.6% -676.8% -3,715.7% – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?